Next Article in Journal
Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality
Next Article in Special Issue
Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma
Previous Article in Journal
Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?
Previous Article in Special Issue
The Road to a Cure: Emerging Treatments for Multiple Myeloma
 
 
Review

Article Versions Notes

Cancers 2021, 13(7), 1686; https://doi.org/10.3390/cancers13071686
Action Date Notes Link
article pdf uploaded. 2 April 2021 13:15 CEST Version of Record https://www.mdpi.com/2072-6694/13/7/1686/pdf-vor
article xml file uploaded 6 April 2021 15:04 CEST Original file -
article xml uploaded. 6 April 2021 15:04 CEST Update https://www.mdpi.com/2072-6694/13/7/1686/xml
article pdf uploaded. 6 April 2021 15:04 CEST Updated version of record https://www.mdpi.com/2072-6694/13/7/1686/pdf
article html file updated 6 April 2021 15:05 CEST Original file -
article html file updated 7 April 2021 10:00 CEST Update -
article html file updated 11 April 2021 02:41 CEST Update -
article html file updated 11 April 2021 03:08 CEST Update -
article html file updated 4 August 2021 03:19 CEST Update -
article html file updated 4 August 2021 03:29 CEST Update -
article html file updated 25 July 2022 10:34 CEST Update -
article html file updated 2 September 2025 02:36 CEST Update https://www.mdpi.com/2072-6694/13/7/1686/html
Back to TopTop